GCC In-Vitro Diagnostics Market Share

Statistics for the 2023 & 2024 GCC In-Vitro Diagnostics market share, created by Mordor Intelligence™ Industry Reports. GCC In-Vitro Diagnostics share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Home Market Analysis Healthcare Research Medical Devices Research Diagnostic Devices Research In Vitro Diagnostic Devices Research GCC In Vitro Diagnostics Industry Market Share

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of GCC In-Vitro Diagnostics Industry

The Gulf Cooperation Council (GCC) In-Vitro Diagnostics Market is moderately fragmented due to the presence of many companies operating regionally. The competitive landscape includes an analysis of a few international and local companies that hold market shares and are well known. Some of the major players in the market are Abbott Laboratories, Danaher Corporation, BioMerieux SA, Sysmex Corporation, F. Hoffmann-La Roche AG, Becton, Dickinson and Company, Siemens Healthineers (Siemens Healthcare GmbH), Qiagen NV, Thermo Fischer Scientific Inc., Grifols SA among others.

GCC In-Vitro Diagnostics Market Leaders

  1. Abbott Laboratories.

  2. Danaher Corporation

  3. F. Hoffmann-La Roche AG

  4. Becton, Dickinson and Company

  5. Sysmex Corporation

*Disclaimer: Major Players sorted in no particular order

GCC In-Vitro Diagnostics Market Major Players

GCC In Vitro Diagnostics Market Report Snapshots

GCC In Vitro Diagnostics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)